Today: 26 June 2026

authID (AUID) Soars After Joining NVIDIA Connect: How Today’s AI Security Deal Could Reshape Its Future

authID (AUID) Soars After Joining NVIDIA Connect: How Today’s AI Security Deal Could Reshape Its Future

authID Inc. shares jumped after the company announced acceptance into the NVIDIA Connect Program, giving it access to NVIDIA’s AI and GPU technologies. The move comes two days after authID launched its Mandate Framework, a governance model for AI agents that ties each agent to a verified human using biometric credentials. Reuters noted the partnership centers on AI agent security, not a direct commercial deal.
20 November 2025
·
Bonk, Inc. (BNKK) Stock Jumps on Q3 2025 Earnings: Debt-Free Balance Sheet and 1,200% Beverage Revenue Surge

Bonk, Inc. (BNKK) Stock Jumps on Q3 2025 Earnings: Debt-Free Balance Sheet and 1,200% Beverage Revenue Surge

Bonk, Inc. reported Q3 2025 beverage revenue of $1.51 million, up over 1,200% year over year, and posted its first-ever gross profit in the segment. The company ended the quarter debt-free with about $9 million in cash. Shares surged Thursday as investors reacted to the results. Net loss remained large, mainly due to $17 million in one-time non-cash charges.
20 November 2025
··
Founder Group Limited (FGL) on 20 November 2025: Nasdaq Warning, Surging Penny Stock, and a RM1.16 Billion Solar Megaproject

Founder Group Limited (FGL) on 20 November 2025: Nasdaq Warning, Surging Penny Stock, and a RM1.16 Billion Solar Megaproject

Founder Group Limited shares surged to $0.40–$0.42 on November 20, 2025, with volume topping 6 million after a pre-market jump of nearly 20%. The Malaysia-based solar firm faces a Nasdaq delisting threat after receiving a minimum bid-price warning, with a deadline to regain compliance by May 2026. The company, listed in October 2024, has no U.S. operations and focuses on large-scale and commercial solar projects in Malaysia.
20 November 2025
·
Inspire Veterinary Partners (IVP) Plunges Over 60%, Then Rebounds as Nasdaq Delisting Deadline Hits Today

Inspire Veterinary Partners (IVP) Plunges Over 60%, Then Rebounds as Nasdaq Delisting Deadline Hits Today

Inspire Veterinary Partners shares rebounded to $0.15 Thursday after plunging over 58% Wednesday on news of a Nasdaq delisting threat. The company faces a critical appeal deadline today to avoid suspension after failing to meet the $1 minimum bid price. Trading volume topped 200 million shares amid intense speculation. Nasdaq plans to suspend trading November 24 unless IVP requests a hearing.
20 November 2025
Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions (J) Beats Q4 2025 Estimates, Targets 16% EPS Growth for 2026 on Record Backlog

Jacobs Solutions reported Q4 2025 revenue of $3.15–3.2 billion, up 6.6%, and adjusted EPS of $1.75, up 28%, both above analyst estimates. GAAP net income fell to $122 million from $325 million a year earlier, mainly due to prior investment gains. Backlog reached a record $23.1 billion. Full-year adjusted EPS rose nearly 16% to $6.12 despite a sharp drop in GAAP earnings.
20 November 2025
··
Freight Technologies (FRGT) Seals Fetch AI Deal and $1M Financing as Zayren Launch Supercharges Volatile Rally

Freight Technologies (FRGT) Seals Fetch AI Deal and $1M Financing as Zayren Launch Supercharges Volatile Rally

Freight Technologies announced a multi-year AI services deal with Fetch Compute and launched its new Zayren platform, triggering FRGT shares to surge over 70% intraday Wednesday. The company issued $1 million in convertible notes and canceled a prior $5.2 million FET token agreement, including returning 11.3 million tokens. Fetch will receive equity and usage credits as part of the new AI partnership.
20 November 2025
···
GE Vernova (GEV) Rallies Again on Taiwan Wind Deal and B20 Grid Breakthrough – Key Updates for 20 November 2025

GE Vernova (GEV) Rallies Again on Taiwan Wind Deal and B20 Grid Breakthrough – Key Updates for 20 November 2025

GE Vernova shares climbed 3.2% to $614 on Thursday, extending a two-day rally sparked by its first international onshore wind repower contract with Taiwan Power Company. The deal covers 25 turbine upgrades and a five-year service agreement. Shares are up 69% year-to-date, with analysts noting the stock’s high valuation at about 50 times earnings.
20 November 2025
·
NetEase (NTES) Q3 2025 Earnings Today: Revenue Miss, $5B Buyback Extension and Blizzard Pipeline Move the Stock

NetEase (NTES) Q3 2025 Earnings Today: Revenue Miss, $5B Buyback Extension and Blizzard Pipeline Move the Stock

NetEase reported Q3 2025 net revenue of RMB 28.4 billion, up 8.2% year over year but below analyst estimates. Shares fell 3–4% pre-market before rebounding to $138, about 3% above the prior close. The company extended its $5 billion share buyback program and declared a new dividend. Gaming growth and new Blizzard titles remain central to its outlook.
20 November 2025
···
Applied Digital (APLD) Soars on Nov. 20 as Babcock & Wilcox Power Deal, $2.35B Notes Offering and AI “Factory” Buildout Collide

Applied Digital (APLD) Soars on Nov. 20 as Babcock & Wilcox Power Deal, $2.35B Notes Offering and AI “Factory” Buildout Collide

Applied Digital shares rose about 10% to $25–26 on Thursday after news of a $1.5 billion power agreement with Babcock & Wilcox for an AI data center project. The deal includes plans for a 300-megawatt natural-gas plant slated for 2028. The stock is now up over 200% year-to-date amid heavy trading and recent financing headlines.
20 November 2025
···
Micron Stock Today (MU): UBS Lifts Price Target to $275 as AI Memory Boom Collides With Capex Fears – November 20, 2025

Micron Stock Today (MU): UBS Lifts Price Target to $275 as AI Memory Boom Collides With Capex Fears – November 20, 2025

UBS raised its price target for Micron Technology to $275, citing fully booked high-bandwidth memory capacity through 2026 and tight supply. Shares traded around $220 Thursday, down 2.5% on the day but up over 170% year to date. Executives warned of higher capital spending at an RBC conference, unsettling some investors. UBS projects FY2026 EPS of $16–17 per share.
20 November 2025
····
Cerence (CRNC) Stock Soars After Q4 2025 Earnings Beat and Bold FY26 AI Guidance – November 20, 2025

Cerence (CRNC) Stock Soars After Q4 2025 Earnings Beat and Bold FY26 AI Guidance – November 20, 2025

Cerence Inc. shares jumped 38% to $10.95 in early trading Thursday after reporting Q4 revenue of $60.6 million, beating estimates and guidance. The company posted a Q4 net loss of about $13.4 million, improved from last year, and Q4 adjusted EBITDA of $8.3 million. Full-year free cash flow reached $46.8 million, nearly triple the prior year. Cerence technology was used in about 52% of global auto production over the past year.
20 November 2025
··
InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals shares surged over 20% in after-hours and pre-market trading following new preclinical data for its Alzheimer’s candidate INM-901. The company reported successful large-animal studies showing robust bioavailability and no adverse neurological effects. INM traded in the $1.49–$1.55 range Thursday morning on heavy volume, with market cap estimates between $3–5 million.
20 November 2025
···
Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio shares surged 49% to $7.15 on November 20, 2025, hitting a three-year high after Q3 revenue of $13.1 million nearly doubled analyst estimates. Uptake of its lung-cancer drug IBTROZI drove $7.7 million in U.S. sales and 204 new patient starts. Multiple analysts raised price targets, with the average now at $10.13. Trading volume spiked, extending a multi-day rally.
20 November 2025
·
Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

WeShop (WSHP) Stock Today, 20 November 2025: U.S. App Launch, 500% Rally and Sharp Pre‑Market Selloff

WeShop Holdings’ U.S. social-commerce app launched 20 November as its Nasdaq-listed shares plunged up to 41% pre-market after a 506% surge to $200 the previous day. The stock, which debuted at $20.02 on 14 November, briefly touched $228 amid heavy volatility and repeated trading halts. Market cap estimates now range from $2.5 to $6.8 billion, despite trailing revenue under $2 million and steep losses.
20 November 2025
··
Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

Nvidia beat earnings forecasts and raised its revenue outlook, sending U.S. stock futures sharply higher Thursday. FOMC minutes show many Fed officials oppose a December rate cut, citing stalled inflation progress. The U.S. August trade deficit narrowed 24% to $59.6 billion. EIA data show crude oil inventories fell by 3.4 million barrels last week.
20 November 2025
····
Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025

Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025

Psyence BioMed (NASDAQ: PBM) secured a sustainable supply of pharmaceutical-grade ibogaine through PsyLabs, receiving an initial 50 kg shipment of high-potency iboga bark for processing. PBM shares rose 21.5% to $3.39 in pre-market trading Thursday, after being named among top healthcare movers.
20 November 2025
···
Bath & Body Works (BBWI) Stock Hit by Q3 2025 Miss, Holiday Sales Warning and New ‘Consumer First’ Turnaround Plan

Bath & Body Works (BBWI) Stock Hit by Q3 2025 Miss, Holiday Sales Warning and New ‘Consumer First’ Turnaround Plan

Bath & Body Works shares fell sharply Thursday after the company missed third-quarter earnings estimates, cut its full-year forecast, and warned of weaker holiday demand. Net sales for Q3 dropped 1% to $1.594 billion, with net income falling to $77 million from $106 million a year ago. The stock traded near $21, down 46% year to date. The company now expects full-year sales to decline and EPS of at least $2.83.
20 November 2025
··
1 … 1,747 1,748 1,749 1,750 1,751 … 2,109

Stock Market Today

  • SpaceX Employees Profit from IPO While Blue Origin Staff Miss Out
    June 26, 2026, 7:51 AM EDT. SpaceX employees have reaped significant financial rewards following the company's IPO, highlighting a stark contrast with Blue Origin workers who have not benefited similarly. The SpaceX public offering has allowed employees to convert stock options into tangible wealth, a key element in attracting and retaining talent in the competitive aerospace industry. Meanwhile, Blue Origin's private status has limited employee access to such liquidity events despite both companies operating in the same sector. This disparity underscores broader trends in equity compensation and liquidity opportunities within private versus public firms in the high-tech space market.

Latest News

Triller jumps, SpaceX stake now values above its market cap

Triller jumps, SpaceX stake now values above its market cap

26 June 2026
Triller shares soared 95% premarket after revealing a $411.3 million SpaceX-linked purchase—nearly seven times its equity value at Thursday’s close—though the deal, still pending escrow and conditions, highlights a massive size mismatch and comes as Triller faces a $346 million working-capital deficit and warns its cash is insufficient for the next year.
Intel (NASDAQ: INTC) Gets an Apple Premium, Math Shows Little Room Left

Intel’s 2026 gains meet pressure with chip shares down premarket

26 June 2026
Intel tumbled over 3% premarket as chip stocks slid, with shares now trading nearly 30% above Wall Street’s average 12-month target despite a $3.7 billion quarterly loss and warnings that next-gen chip work could pause without more demand; investors await Q2 results July 23, with EPS seen at 21 cents.
Go toTop